Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1400 of 1674 entries
View as:

Shared Decision Making in Older Adults With Distal Radius Fractures

Phase: N/A Priority: Normal
NCT ID: NCT02782299 Org: User:
Start: 12/31/15 End: 11/30/18 Due: 11/30/19

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00540007 Org: User:
Start: 09/06/07 End: 09/01/16 Due: 09/01/17

Testing the Decision Aid: Supporting Patient Decisions About Upper Extremity Surgery in Cervical SCI

Phase: N/A Priority: Normal
NCT ID: NCT04995796 Org: User:
Start: 12/01/21 End: 08/22/22 Due: 08/22/23

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00324259 Org: User:
Start: 08/31/04 End: 08/31/14 Due: 08/31/15

Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01566435 Org: User:
Start: 08/09/12 End: 10/31/19 Due: 10/31/20

Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)

Phase: N/A Priority: Normal
NCT ID: NCT00455325 Org: User:
Start: 09/30/04 End: 03/31/12 Due: 03/31/13

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

Phase: N/A Priority: Normal
NCT ID: NCT00353483 Org: User:
Start: 09/14/05 End: 08/31/25 Due: 08/31/26

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02204098 Org: User:
Start: 01/07/15 End: 08/31/28 Due: 08/31/29

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT02611180 Org: User:
Start: 04/30/15 End: 04/30/26 Due: 04/30/27

Processing Speed as an Objective Measure of Tinnitus

Phase: N/A Priority: Normal
NCT ID: NCT01222507 Org: User:
Start: 07/31/10 End: 10/31/10 Due: 10/31/11

Migraine in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT05654012 Org: User:
Start: 06/01/23 End: 03/15/30 Due: 03/15/31

Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06008808 Org: User:
Start: 05/07/24 End: 12/11/26 Due: 12/11/27

Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05905705 Org: User:
Start: 03/07/23 End: 07/31/27 Due: 07/31/28

Local Ablative Strategies After Endovascular Radioembolization

Phase: N/A Priority: Normal
NCT ID: NCT02611661 Org: User:
Start: 01/19/16 End: 02/13/18 Due: 02/13/19

Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use

Phase: N/A Priority: Normal
NCT ID: NCT01579773 Org: User:
Start: 04/30/10 End: 08/31/14 Due: 08/31/15

A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair

Phase: N/A Priority: Normal
NCT ID: NCT03450473 Org: User:
Start: 01/03/18 End: 12/31/22 Due: 12/31/23

Regulation of Hepatic Insulin Extraction

Phase: N/A Priority: Normal
NCT ID: NCT00811044 Org: User:
Start: 10/31/00 End: 06/30/15 Due: 06/30/16

Telemedicine Control Tower for the Post-Anesthesia Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT04020887 Org: User:
Start: 03/01/20 End: 12/06/21 Due: 12/06/22

Disseminating Public Health Evidence to Support State Health Department Prevention of Cancer and Other Chronic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT01978054 Org: User:
Start: 09/30/13 End: 03/31/18 Due: 03/31/19

Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance

Phase: N/A Priority: Normal
NCT ID: NCT02756962 Org: User:
Start: 07/06/16 End: 07/31/29 Due: 07/31/30

Efficacy of a Multi-level School Intervention for LGBTQ Youth

Phase: N/A Priority: Normal
NCT ID: NCT05541406 Org: User:
Start: 09/14/22 End: 12/01/25 Due: 12/01/26

Use of Thalidomide in Patients With Arachnoiditis

Phase: N/A Priority: Normal
NCT ID: NCT00284505 Org: User:
Start: 07/31/05 End: 07/31/06 Due: 07/31/07

Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia

Phase: N/A Priority: Normal
NCT ID: NCT05542095 Org: User:
Start: 05/01/23 End: 05/01/23 Due: 05/01/24

Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling

Phase: N/A Priority: Normal
NCT ID: NCT03946774 Org: User:
Start: 10/01/19 End: 05/04/23 Due: 05/04/24

Resect and Discard Approach to Diminutive Colonic Polyps

Phase: N/A Priority: Normal
NCT ID: NCT01877525 Org: User:
Start: 10/31/11 End: 10/31/12 Due: 10/31/13